Compounds > naltrexone

naltrexone and Alcohol Abuse, Nervous System

naltrexone has been researched along with Alcohol Abuse, Nervous System in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chin, PF; Miotto, K; Ray, LA1
Olive, MF1
O'Brien, C1
Beadles-Bohling, AS; Wiren, KM1

Reviews

1 review(s) available for naltrexone and Alcohol Abuse, Nervous System

ArticleYear
Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.
    CNS & neurological disorders drug targets, 2010, Volume: 9, Issue:1

    Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Brain; Brain Chemistry; Genetic Predisposition to Disease; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu

2010

Other Studies

3 other study(ies) available for naltrexone and Alcohol Abuse, Nervous System

ArticleYear
Pharmacotherapies for alcoholism: the old and the new.
    CNS & neurological disorders drug targets, 2010, Volume: 9, Issue:1

    Topics: Acamprosate; Alcohol Deterrents; Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Disease Models, Animal; Disulfiram; Drug Design; Humans; Naltrexone; Narcotic Antagonists; Neuropeptides; Neuropharmacology; Neurotransmitter Agents; Receptors, Neurotransmitter; Taurine

2010
A patient-supported clinical trial.
    Annals of neurology, 2010, Volume: 68, Issue:2

    Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Clinical Trials as Topic; Humans; Naltrexone; Narcotic Antagonists

2010
Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal.
    Genes, brain, and behavior, 2006, Volume: 5, Issue:6

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Alcohol-Induced Disorders, Nervous System; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Anticonvulsants; Brain; Central Nervous System Depressants; Disease Models, Animal; Drug Interactions; Drug Synergism; Ethanol; Male; Naltrexone; Receptors, Opioid, kappa; Seizures; Species Specificity; Substance Withdrawal Syndrome; Treatment Outcome

2006